NewAmsterdam Pharma NAMS SEC Filings

NASDAQ NAMS
$20.72 +1.54 (+8.03%)
At close: Nov 11, 2026 · 4:00 PM EST
EDGAR Disclosures

SEC Filings

Source SEC EDGAR

Every SEC filing NewAmsterdam Pharma Co N.V. (NAMS) has made, as reported on EDGAR — annual and quarterly reports, current reports, insider transactions and ownership disclosures. Filter by form group, form type or period, and open any filing or its index directly.

Form Type
# Form Type Form Group Accession Date Filing Index
110-QQuarterly & Annual Report0001193125-26-446228Nov 4, 2026 12:40 PM
28-KCurrent Report0001193125-26-446219Nov 4, 2026 12:35 PM
34Insider Transaction0001193125-26-412431Oct 2, 2026 12:30 AM
48-KCurrent Report0001193125-26-406063Sep 29, 2026 8:22 AM
5SCHEDULE 13DBeneficial Ownership Report0001231919-26-001215Sep 22, 2026 8:58 PM
68-KCurrent Report0001193125-26-396716Sep 21, 2026 8:30 PM
74Insider Transaction0001193125-26-391985Sep 15, 2026 8:30 PM
84Insider Transaction0001193125-26-386508Sep 9, 2026 8:30 PM
94Insider Transaction0001193125-26-381953Sep 3, 2026 8:30 PM
10144Insider Transaction0001968582-26-000878Aug 25, 2026 8:47 PM
114Insider Transaction0001193125-26-365202Aug 25, 2026 8:30 PM
12144Insider Transaction0001968582-26-000868Aug 24, 2026 8:55 PM
138-KCurrent Report0001193125-26-352233Aug 14, 2026 8:10 PM
143Insider Transaction0001193125-26-352209Aug 14, 2026 8:07 PM
158-KCurrent Report0001193125-26-352186Aug 14, 2026 8:05 PM
16SCHEDULE 13GBeneficial Ownership Report0000315066-26-002082Aug 6, 2026 2:33 PM
178-KCurrent Report0001193125-26-333827Aug 5, 2026 11:08 AM
1810-QQuarterly & Annual Report0001193125-26-333824Aug 5, 2026 11:06 AM
198-KCurrent Report0001193125-26-315163Jul 24, 2026 12:03 PM
208-KCurrent Report0001193125-26-312390Jul 22, 2026 8:05 PM
214Insider Transaction0001193125-26-312387Jul 22, 2026 8:05 PM
224Insider Transaction0001193125-26-281062Jun 24, 2026 8:10 PM
23S-8Prospectus0001193125-26-259794Jun 5, 2026 8:41 PM
24SCHEDULE 13GBeneficial Ownership Report0001422849-26-000108Jun 4, 2026 10:32 PM
258-KCurrent Report0001193125-26-254615Jun 3, 2026 11:58 AM
264Insider Transaction0001193125-26-241983May 27, 2026 8:30 PM
27144Insider Transaction0001968582-26-000491May 26, 2026 9:04 PM
28SCHEDULE 13DBeneficial Ownership Report0001193125-26-224656May 14, 2026 11:52 PM
298-KCurrent Report0001193125-26-210283May 7, 2026 11:02 AM
3010-QQuarterly & Annual Report0001193125-26-210272May 7, 2026 11:00 AM
31SCHEDULE 13GBeneficial Ownership Report0000315066-26-001273May 6, 2026 3:30 PM
32ARSOthers0001193125-26-207564May 6, 2026 11:22 AM
33DEF 14AOthers0001193125-26-207562May 6, 2026 11:20 AM
348-KCurrent Report0001193125-26-177406Apr 24, 2026 8:30 PM
35PRE 14AOthers0001193125-26-162757Apr 20, 2026 12:00 PM
364Insider Transaction0001193125-26-104239Mar 12, 2026 8:25 PM
37144Insider Transaction0001968582-26-000272Mar 11, 2026 8:08 PM
384Insider Transaction0001193125-26-100798Mar 10, 2026 12:58 AM
394Insider Transaction0001193125-26-099073Mar 9, 2026 12:18 AM
40144Insider Transaction0001968582-26-000241Mar 6, 2026 10:52 PM
41144Insider Transaction0001968582-26-000230Mar 5, 2026 9:14 PM
424Insider Transaction0001193125-26-085947Mar 2, 2026 11:08 PM
43144Insider Transaction0001968582-26-000187Mar 2, 2026 9:10 PM
448-KCurrent Report0001193125-26-084266Mar 2, 2026 1:00 PM
454Insider Transaction0001193125-26-078718Feb 26, 2026 2:40 AM
464Insider Transaction0001193125-26-067260Feb 24, 2026 9:40 PM
47144Insider Transaction0001968582-26-000152Feb 24, 2026 9:22 PM
48144Insider Transaction0002085929-26-000002Feb 20, 2026 12:51 PM
49S-8Prospectus0001193125-26-056037Feb 18, 2026 12:07 PM
5010-KQuarterly & Annual Report0001193125-26-056029Feb 18, 2026 12:00 PM
...

NewAmsterdam Pharma Co N.V. SEC Filings API

Pull NewAmsterdam Pharma Co N.V.'s SEC filing index, with links to every filing and exhibit, into your own tools with the Business Quant SEC Filings API. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/secfilings?ticker=NAMS&formtype=10-K,10-Q&api_key=YOUR_API_KEY